Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases
Clinical trial NCT07570914 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07570914
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2027-05-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.